4//SEC Filing
KANNAN RAJ 4
Accession 0001209191-22-020654
CIK 0001337553other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 8:26 PM ET
Size
5.7 KB
Accession
0001209191-22-020654
Insider Transaction Report
Form 4
KANNAN RAJ
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-18+197,239→ 197,239 totalExercise: $8.80Exp: 2032-03-18→ Common Stock (197,239 underlying)
Footnotes (1)
- [F1]This Option was granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on March 18, 2023 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of March 18, 2023.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001778539
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 8:26 PM ET
- Size
- 5.7 KB